CardioMEMS HF System Post Approval Study

NCT02279888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1214

Last updated 2024-04-17

Study results available
· View outcomes & findings →

Summary

The purpose of the CardioMEMS HF System Post Approval Study (PAS) is to evaluate the use of the CardioMEMS HF System in patients with NYHA class III heart failure in a commercial setting.

Conditions

  • Heart Failure
  • Left-Sided Heart Failure
  • Congestive Heart Failure

Interventions

DEVICE

CardioMEMS HF System

Pulmonary artery pressure sensor

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Lynne Stevenson, MD · Brigham and Women's

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-10-11
Completion
2019-10-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02279888 on ClinicalTrials.gov